Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection

American Journal of Psychiatry

Volumn 159, Issue 10, 2002, Pages 1752-1759

  Evans, Dwight L ^a   Ten Have, Thomas R ^a   Douglas, Steven D ^a   Gettes, David R ^a   Morrison, Mary ^a   Chiappini, Margaret S ^a   Brinker Spence, Priscilla ^a   Job, Carla ^a   Mercer, Delinda E ^a   Wang, Yan Lin ^a   Cruess, Dean ^a   Dube, Benoit ^a   Dalen, Erik A ^a   Brown, Tiffany ^a   Bauer, Russell ^a   Petitto, John M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; BLOOD CELL COUNT; CELLULAR IMMUNITY; CLINICAL EXAMINATION; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HAMILTON SCALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; PRIORITY JOURNAL; SUBSTANCE ABUSE; SUPPRESSOR CELL; SYMPTOMATOLOGY; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD;

ADULT; AGED; ANXIETY DISORDERS; BLOOD CELL COUNT; CD8-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; COMORBIDITY; DEPRESSIVE DISORDER; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; KILLER CELLS, NATURAL; LONGITUDINAL STUDIES; MIDDLE AGED; SEX FACTORS; VIRAL LOAD;

EID: 0036787401     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.159.10.1752     Document Type: Article

References (65)

1. Evans DL, Mason K, Bauer R, Leserman J, Petitto J: Neuropsychiatric manifestations of HIV-1 infection and AIDS, in Psychopharmacology: The Fifth Generation of Progress. Edited by Davis KL, Charney D, Coyle JT, Nemeroff C. New York, Raven Press, 2002, pp 1281-1300
2. Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, Boland RJ, Moore J (HIV Epidemiology Research Study Group): Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women. JAMA 2001; 285:1466-1474
3. Page-Schaeffer K, Delonenze GN, Satariano WA, Winkelstein W: Comorbidity and survival in HIV-infected men in the San Francisco Men's Health Survey. Ann Epidemiol 1996; 6:420-430
4. Mayne TJ, Vittinghoff E, Chesney MA, Barrett DC, Coates TJ: Depressive affect and survival among gay and bisexual men infected with HIV. Arch Intern Med 1996; 156:2233-2238
5. Leserman J, Jackson ED, Petitto JM, Golden RN, Silva SG, Perkins DO, Cai J, Folds JD, Evans DL: Progression to AIDS: the effects of stress, depressive symptoms, and social support. Psychosom Med 1999; 61:397-406
6. Herbert TB, Cohen S: Depression and immunity: a meta-analytical review. Psychol Bull 1993; 113:472-486
7. Evans DL, Leserman J, Pederson CA, Golden RN, Lewis MH, Folds JA, Ozer H: Immune correlates of stress and depression. Psychopharmacol Bull 1989; 25:319-324
8. Stein M, Miller AH, Trestman RL: Depression, the immune system and health and illness. Arch Gen Psychiatry 1991; 48:171-177
9. Reichlin S: Mechanisms of disease: neuroendocrine-immune interactions. N Engl J Med 1993; 239:1246-1253
10. Evans DL, Folds JD, Petitto JM, Golden RN, Pedersen CA, Corrigan M, Gilmore JH, Silva SG, Quade D, Ozer H: Circulating natural killer cell phenotypes in men and women with major depression. Arch Gen Psychiatry 1992; 49:388-395
11. Evans DL, Leserman J, Perkins DO, Stern RA, Murphy C, Tamul K, Liao D, van der Horst CM, Hall CD, Folds JD, Golden RN, Petitto JM: Stress-associated reductions of cytotoxic T lymphocytes and natural killer cells in asymptomatic HIV infection. Am J Psychiatry 1995; 152:543-550
12. Leserman J, Petitto JM, Perkins DO, Folds JD, Golden RN, Evans DL: Severe stress, depressive symptoms, and changes in lymphocyte subsets in human immunodeficiency virus-infected men: a 2-year follow-up study. Arch Gen Psychiatry 1997; 54: 279-285
13. Burack JH, Barrett DC, Stall RD, Chesney MA, Ekstrand ML, Coates TJ: Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. JAMA 1993; 270:2568-2573
14. Kemeny ME, Weiner H, Taylor SE, Schneider S, Visscher B, Fahey JL: Repeated bereavement, depressed mood, and immune parameters in HIV seropositive and seronegative gay men. Health Psychol 1994; 13:14-24
15. Chehimi J, Starr SE, Frank I, Rengaraju SJ, Jackson C, Llanes M, Kobayashi B, Perussia D, Young E, Nickbarg SF, Wolf SK, Trinchieri G: Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J Exp Med 1992; 175:789-796
16. Whiteside TL, Herberman RB: Role of human natural killer cells in health and disease. Clin Diagn Lab Immunol 1994; 1:125-133
17. Levy JA: HIV and the Pathogenesis of AIDS. Washington, DC, ASM Press, 1998
18. Oliva A, Kinter AL, Vaccarezza M, Rubbert A, Catanzaro A, Moir S, Monaco J, Ehler L, Mizell S, Jackson R, Li Y, Romano JW, Fauci AS: Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. J Clin Invest 1998; 102:223-231
19. Jassoy C, Harrer T, Rosenthal T, Bradford AN, Worth J, Johnson RP, Walker BD: Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNFα) and TNFβ when they encounter their target antigens. J Virol 1993; 67:2844-2852
20. Ho HN, Hultin LE, Mitsuyasu RT, Matud JL, Hausner MA, Bockstoce D, Chou CC, O'Rourke S, Taylor JM, Giorgi JV: Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens. J Immunol 1993; 150:3070-3079
21. Fauci AS, Pantaleo G, Stanley S, Weissman D: Immunopathogenic mechanisms of HIV infection. Ann Intern Med 1996; 124: 654-663
22. Ferbas J: Perspectives on the role of CD8+ cell suppressor factors and cytotoxic T lymphocytes during HIV infection. Neuroimmunomodulation 1997; 4:42-48
23. Greenberg P, Riddell S: Deficient cellular immunity - finding and fixing the defects. Science 1999; 285:546-551
24. Famularo G, Moretti S, Marcellini S, Nucera E, De Simone C: CD8 lymphocytes in HIV infection: helpful and harmful. J Clin Lab Immunol 1997; 49:15-32
25. Perrit D, Sesok-Pizzini DA, Schretzenmair R, Macgregor RR, Valiante NM, Tu X, Trinchieri G, Kamoun M: C1.7 antigen expression on CD8+ T cells is activation dependent: increased proportion of C1.7+CD8+ T cells in HIV-1 infected patients with progressing disease. J Immunol 1999; 162:7563-7568
26. Gea-Banacloche JC, Migueles SA, Martino L, Shupert WL, McNeil AC, Saggaghian MS, Ehler L, Prussin C, Stevens R, Lambert L, Altman J, Hallahan CW, de Quiros JC, Connors M: Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors. J Immunol 2000; 165:1082-1092
27. Gamberg JC, Bowmer MI, Trahey JC, Campbell CM, Pardo I, Grant MD: Functional and genetic integrity of the CD8 T-cell repertoire in advanced HIV infection. AIDS 1999; 13:2043-2053
28. Levy JA: The importance of the innate immune system in controlling HIV infection and disease. Trends Immunol 2001; 22: 312-316
29. Liu Z, Cumberland WG, Hultin LE, Kaplan AH, Detels R, Giorgi JV: CD8+ T-lymphocytes activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency. J Acquir Immune Defic Syndr 1998; 18:332-340
30. Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, Jacobson LP, Shih R, Lewis J, Wiley DJ, Phair JP, Wolinsky SM, Detels R: Shorter survival in advanced human immunodeficiency virus Type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999; 179:859-870
31. Perkins DO, Dickison JA, Evans DL: SCID-RDC: DSM-III-R and RDC integrated interview, in New Research Program and Abstracts, 143rd Annual Meeting of the American Psychiatric Association. Washington, DC, APA, 1990
32. Perkins DO, Stern RA, Golden RN, Murphy C, Naftolowitz D, Evans DL: Mood disorders in HIV infection: prevalence and risk factors in a nonepicenter of the AIDS epidemic. Am J Psychiatry 1994; 151:233-236
33. Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6:278-296
34. Hamilton M: The assessment of anxiety states by rating. Br J Med Psychol 1959; 32:50-55
35. Petitto JM, Folds JD, Ozer H, Quade D, Evans DL: Altered diurnal variation in circulating natural killer cell phenotypes and cytotoxic activity in major depression. Am J Psychiatry 1992; 148: 694-696
36. Douglas SD, Rudy B, Muenz L, Mcscicki AB, Wilson CM, Holland C, Crowley-Nowick P, Vermund SH: Peripheral blood mononuclear cell makers in antiretroviral therapy-naive HIV infected and high risk HIV seronegative adolescents. AIDS 1999; 13:1629-1635
37. Douglas SD, Durako SJ, Tustin N, Houser J, Muenz L, Starr SE, Wilson C (Adolescent Medicine HIV/AIDS Research Network): Natural killer cell enumeration and function in HIV infected and high risk uninfected adolescents. AIDS Res Hum Retroviruses 2001; 17:543-552
38. Bryant J, Day R, Whiteside TL, Herbeman RB: Calculation of lytic units for the expression of cell-medicated cytotoxicity. J Immunol Methods 1992; 146:91-103
39. Friberg D, Bryant JL, Whiteside TL: Measurements of natural killer (NK) activity and NK-cell quantification. Methods 1996; 9: 316-326
40. Whiteside TL: Measurement of NK-cell activity in humans, in Manual of Clinical Laboratory Immunology, 6th ed. Edited by Rose NR, Hamilton RG, Detrick B. Washington, DC, ASM Press, 2001, pp 296-300
41. Rao CR: Linear Statistical Inference and Its Applications. New York, John Wiley & Sons, 1973, p 499
42. Tyler DS, Stanley SD, Nastala CA, Austin AA, Bartlett JA, Stine KC, Lyerly HK, Bolognesi DP, Weinold KJ: Alterations in antibody-dependent cellular cytoxicity during the course of HIV-1 infection: humoral and cell defects. J Immunol 1990; 144:3375-3384
43. Walker BD, Plata F: Cytotoxic T lymphocytes against HIV. AIDS 1990; 4:177-184
44. Fauci AS: Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 1993; 262:1011-1018
45. Paul WE: Reexamining AIDS research priorities. Science 1995; 267:633-636
46. Perry S, Fishman B, Jacobsberg L, Frances A: Relationships over 1 year between lymphocyte subsets and psychosocial variables among adults with infection by human immunodeficiency virus. Arch Gen Psychiatry 1992; 49:396-401
47. Rabkin JG, Williams JB, Remien RH, Goetz R, Kertzner R, Gorman JM: Depression, distress lymphocyte subsets, and human immunodeficiency virus symptoms on two occasions in HIV-positive homosexual men. Arch Gen Psychiatry 1991; 48:111-119
48. Gorman JM, Kertzner R, Cooper T, Goetz RR, Lagomasino I, Novacenko H, Williams JB, Stern Y, Mayeux R, Ehrhardt AA: Glucocorticoid level and neuropsychiatric symptoms in homosexual men with HIV infection. Am J Psychiatry 1991; 148:41-45
49. Rovner BW, Garman PS, Brent LJ, Clark R, Burton L, Folstein MF: Depression and mortality in nursing homes. JAMA 1991; 265: 993-996
50. Frasure-Smith N, Lesperance F, Talajic M: Depression following myocardial infarction: impact on 6-month survival. JAMA 1993; 270:1819-1825
51. Frasure-Smith N, Lesperance F, Talajic M: Depression and 18-month prognosis after myocardial infarction. Circulation 1995; 91:999-1005
52. Penninx BWJH, Geerlings SW, Deeg DJH, van Eijk JTM, van Tilburg W, Beekman ATF: Minor and major depression and the risk of death in older persons. Arch Gen Psychiatry 1999; 56: 889-895
53. Wulsin LR, Vaillant GE, Wells VE: A systematic review of the mortality of depression. Psychosom Med 1999; 61:6-17
54. Katon W, Von Korff M, Lin E, Walker E, Simon GE, Bush T, Robinson P, Russo J: Collaborative management to achieve treatment guidelines: impact on depression in primary care. JAMA 1995; 273:1026-1031
55. Gordillo V, del Amo J, Soriano V, Gonzalez-Lahov J: Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS 1999; 13:1763-1769
56. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, Wagener MM, Singh N: Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000; 133:21-30
57. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, Wagener MM, Singh N: Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000; 133:21-30
58. Gross R, Bilker WB, Friedman HM, Strom BL: Effect of Adherence to newly initiated antiretroviral therapy on plasma viral load. AIDS 2001, 15:2109-2117
59. DiMatteo MR, Lepper HS, Croghan TW: Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160:2101-2107
60. Gross R, Friedman HM, Bilker WB, Strom BL: Adherence to nelfinavir: magnitude and patterns associated with HIV suppression, in 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC, American Society for Microbiology, 2000, p 295
61. Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, Bamberger JD, Chesney MA, Moss A: Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS 2000; 14:357-366
62. Rabkin JG, Goetz RR, Remien RH, Williams JBW, Todak G, Gorman JM: Stability of mood despite HIV illness progression in a group of homosexual men. Am J Psychiatry 1997; 154:231-238
63. Atkinson J, Grant I, Kennedy CJ, Richman DD, Spector SA, McCutcheon JA: Prevalence of psychiatric disorders among men infected with human immunodeficiency virus: a controlled study. Arch Gen Psychiatry 1988; 45:859-864
64. Williams JBW, Rabkin JG, Remien RH, Gorman JM, Ehrhardt AA: Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection: standardized clinical assessment of current and lifetime psychopathology. Arch Gen Psychiatry 1991; 48:124-130
65. Evans DL, McCartney CF, Nemeroff CB, Raft D, Quade D, Golden RN, Haggerty JJ Jr, Holmes V, Simon JS, Droba M, Mason GA, Fowler WC: Depression in women treated for gynecological cancer: clinical and neuroendocrine assessment. Am J Psychiatry 1986; 143:447-452